Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 6, 2012, Pages 613-627

  Caylak, Emrah ^a  

^a Karatekin University   (Turkey)

Author keywords

Attention deficit hyperactivity disorder; Biochemistry; Candidate gene; Genetic

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENALIN; ADRENIC ACID; ARACHIDONIC ACID; BIOCHEMICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM; CATECHOL METHYLTRANSFERASE; CHROMIUM; DOCOSAPENTAENOIC ACID; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; IRON; LINOLEIC ACID; LINOLENIC ACID; MAGNESIUM; METHYLPHENIDATE; NORADRENALIN; POLYUNSATURATED FATTY ACID; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRACE ELEMENT; UNINDEXED DRUG; ZINC;

5 HTT GENE; ADRA2A GENE; ATTENTION DEFICIT DISORDER; BDNF GENE; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CHRNA4 GENE; COMT GENE; DAT1 GENE; DBH GENE; DOPAMINERGIC SYSTEM; DRD4 GENE; DRD5 GENE; GABAERGIC SYSTEM; GENE; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEREDITY; HTR1B GENE; HTR2A GENE; HUMAN; HUMAN RELATION; HYPOGLYCEMIA; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SNAP25 GENE; SYMPTOM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CHILD; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84864958975     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32077     Document Type: Review

References (136)

1. Agrawal A, Scherrer JF, Grant JD, Sartor CE, Pergadia ML, Duncan AE, Madden PAF, et al. 2010. The effects of maternal smoking during pregnancy on offspring outcomes. Prev Med 50: 13- 18.
2. Anderson RA. 1997. Nutritional factors influencing the glucose/insulin system: Chromium. J Am Coll Nutr 16: 404- 4l0.
3. Arnold LE, DiSilvestro RA. 2005. Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15: 619- 627.
4. Arnsten AF, Li BM. 2005. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57: 1377- 1384.
5. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, Buitelaar J, et al. 2007. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 164: 674- 677.
6. Baker GB, Bornstein RA, Rouget AC, Ashton SE, van Muyden JC, Coutts RT. 1991. Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry 29: 15- 22.
7. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, et al. 2000. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 5: 405- 409.
8. Barroso N, Rodriguez M. 1996. Action of β-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission. Eur J Pharmacol 297: 195- 203.
9. Bekaroǧlu M, Aslan Y, Gedik Y, Deǧer O, Mocan H, Erduran E, Karahan C. 1996. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: A research note. J Child Psychol Psychiatry 37: 225- 227.
10. Bhaduri N, Mukhopadhyay K. 2006. Lack of significant association between -1021C(T) polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci Lett 402: 12- 16.
11. Bhaduri N, Sarkar K, Sinha S, Chattopadhyay A, Mukhopadhyay K. 2010. Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India. Cell Mol Neurobiol 30: 265- 274.
12. Biederman J, Kim JW, Doyle AE, Mick E, Fagerness J, Smoller JW, Faraone SV. 2008. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: A preliminary study. Am J Med Genet Part B 147B: 1511- 1518.
13. Braun JM, Kahn RS, Froelich T, Auinger P, Lamphear BP. 2006. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 114: 1904- 1909.
14. Brookes KJ, Mill J, Guindalini C, Curran S, Xu X, Knight J, Chen CK, et al. 2006a. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 63: 74- 81.
15. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Aneey R, et al. 2006b. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11: 934- 953.
16. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M. 2002. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): Evidence of linkage and association in the Irish population. Mol Psychiatry 7: 913- 917.
17. Carrie I, Clement M, de Javel D, Frances H, Bourre JM. 2000. Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J Lipid Res 41: 473- 480.
18. Caspi A, Langley K, Milne B, Moffitt TE, O'Donovan M, Owen MJ, Polo Tomas M, et al. 2008. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 65: 203- 210.
19. Castellanos FX, Acosta MT. 2002. Syndrome of attention deficit with hyperactivity as the expression of an organic functional disorder. Rev Neurol 35: 1- 11.
20. Castellanos FX, Elia J, Kruesi MJ, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, et al. 1996a. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology 14: 125- 137.
21. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, et al. 1996b. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53: 607- 616.
22. Caylak E. 2007. A review of association and linkage studies for genetical analyses of learning disorders. Am J Med Genet Part B 144B: 923- 943.
23. Caylak E. 2010/2011. The biochemical and cognitive explanation of developmental dyslexia. J Pediatr Biochem 1: 239- 268. DOI: 10.3233/JPB-2010-0020
24. Caylak E. 2011a. Biological/biochemical features and molecular genetics of specific language impairment (SLI). In: Encyclopedia of life sciences. Chichester: John Wiley & Sons, Ltd. pp 1- 6. DOI: 10.1002/9780470015902.a0023688
25. Caylak E. 2011b. Biochemistry and molecular genetics of speech-sound disorder and dyspraxia. In: Encyclopedia of life sciences. Chichester: John Wiley & Sons, Ltd. pp 1- 5. DOI: 10.1002/9780470015902.a0023689
26. Caylak E, Halifeoglu I. 2010. The effects of lead on antioxidants enzymes in children and the therapeutic/prophylactic role of antioxidants. Cocuk Sagligi ve Hastaliklari Dergisi 53: 159- 173 (in Turkish).
27. Caylak E, Halifeoglu I. 2007. Effects of sulfur-containing antioxidants on malondialdehyde and catalase levels of liver, kidney and brain in lead-exposed rats. Turkiye Klinikleri TIP Bilimleri Dergisi 27: 1- 8.
28. Caylak E, Halifeoglu I, Aydin S, Telo S, Bulmus O, Celik H. 2007. The effects of sulfur-containing compounds on total antioxidant capacity levels of liver, kidney and brain in lead-exposed rats. Turkiye Klinikleri TIP Bilimleri Dergisi 27: 823- 828.
29. Caylak E, Aytekin M, Halifeoglu I. 2008. Antioxidant effects of methionine, alpha-lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats. Exp Toxicol Pathol 60: 289- 294.
30. Cheuk DK, Wong V. 2006. Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 36: 651- 659.
31. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56: 993- 998.
32. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. 2004. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: Preliminary findings. J Neuropsychiatry Clin Neurosci 16: 63- 69.
33. Crawford MA. 1992. Essential fatty acids and neurodevelopmental disorder. In: Bazan NG, editor. Neurobiology of essential fatty acids. New York: Plenum Press. pp 307- 314.
34. Cryer PE. 2007. Hypoglycemia, functional brain failure and brain death. J Clin Invest 17: 868- 870.
35. Cubells JF, Zabetian CP. 2004. Human genetics of plasma dopamine-beta-hydroxylase activity: Applications to research in psychiatry and neurology. Psychopharmacology 174: 463- 476.
36. Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J. 2000. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5: 56- 63.
37. Curatolo P, D'Agati E, Moavero R. 2010. The neurobiological basis of ADHD. Ital J Pediatr 36: 79. DOI: 10.1186/1824-7288-36-79
38. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, Huckett L, et al. 2001. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6: 425- 428.
39. Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4: 192- 196.
40. Delion S, Chalon S, Hérault J, Guilloteau D, Besnard JC, Durand G. 1994. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 124: 2466- 2476.
41. Depue RA, Collins PF. 1999. Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci 22: 491- 517.
42. Deupree JD, Smith SD, Kratochvil CJ, Bohac D, Ellis CR, Polaha J, Bylund DB, et al. 2006. Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: Radioligand binding and polymorphism studies. Am J Med Genet Part B 141B: 877- 884.
43. Dvorakova M, Jezova D, Blazicek P, Trebaticka J, Skodacek I, Suba J, Iveta W, et al. 2007. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): Modulation by a polyphenolic extract from pine bark (pycnogenol). Nutr Neurosci 10: 151- 157.
44. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, et al. 1999. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 88: 497- 502.
45. Erikson K, Pinero D, Connor J, Beard J. 1997. Iron status and distribution on iron in the brains of the developing rats. J Nutr 127: 2030- 2038.
46. Faraone SV, Asherson P. 2005. The molecular genetics of ADHD: A view from the IMAGE Project. Psychiatric Times 22(9): 21- 23.
47. Faraone S, Doyle A, Mick E, Biederman J. 2001. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158: 1052- 1057.
48. Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2: 104- 113.
49. Faraone S, Perlis R, Doyle A, Smoller J, Goralnick J, Holmgren M, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1313- 1323.
50. Feng Y, Crosbie J, Wigg K, Pathare T, Ickowicz A, Schachar R, Tannock R, et al. 2005. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry 10: 998- 1005.
51. Friedel S, Saar K, Sauer S, DempXe A, Walitza S, Renner T, Romanos M, et al. 2007. Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol Psychiatry 12: 923- 933.
52. Frier BM. 2001. Hypoglycaemia and cognitive function in diabetes. Int J Clin Pract Suppl 123: 30- 37.
53. Gao X, Su L, Xie G. 2004. Comparison of serum 5-HT level in attention deficit hyperactivity disorder (ADHD) with or without oppositional defiant disorder (ODD). 16th World Congress of the International Association for Child and Adolescent Psychiatry and Aliened Professions, Berlin Germany, Abstracts Book, p 306.
54. Genro JP, Polanczyk GV, Zeni C, Oliveira AS, Roman T, Rohde LA, Hutz MH. 2008. A common haplotype at the dopamine transporter gene 5′ region is associated with attention-deficit/hyperactivity disorder. Am J Med Genet Part B 147B: 1568- 1575.
55. Gizer IR, Ficks C, Waldman ID. 2009. Candidate gene studies of ADHD: A meta-analytic review. Hum Genet 126: 51- 90.
56. Guimaraes AP, Zeni C, Polanczyk GV, Genro JP, Roman T, Rohde LA, Hutz MH. 2007. Serotonin genes and attention deficit/hyperactivity disorder in a Brazilian sample: Preferential transmission of the HTR2A 452His allele to affected boys. Am J Med Genet Part B 144B: 69- 73.
57. Halperin JM, Newcorn JH, Koda VH, Pick L, McKay KE, Knott P. 1997. Noradrenergic mechanisms in ADHD children with and without reading disabilities: A replication and extension. J Am Acad Child Adolesc Psychiatry 36: 1688- 1697.
58. Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M. 2000. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deWcit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet 96: 282- 284.
59. Hawi Z, Dring M, Kirley A, Foley D, Kent L, Craddock N, Asherson P, et al. 2002. Serotonergic system and attention deficit hyperactivity disorder (ADHD): A potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry 7: 718- 725.
60. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nöthen M, Greenwood T, Kelsoe J, et al. 2003. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8: 299- 308.
61. Heiser P, Dempfle A, Friedel S, Konrad K, Hinney A, Kiefl H, Walitza S, et al. 2007. Family-based association study of serotonergic candidate genes and attentiondeficit/hyperactivity disorder in a German sample. J Neural Transm 114: 513- 521.
62. Higley JD, Suomi SJ, Linnoila M. 1992. A longitudinal assessment of CSF monoamine metabolite and plasma cortisol concentrations in young Rhesus monkeys. Biol Psychiatry 32: 127- 145.
63. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. 2003. Genetic associations in large versus small studies: An empirical assessment. Lancet 361: 567- 571.
64. Jump DB. 2002. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 277: 8755- 8758.
65. Juneja M, Jain R, Singh V, Mallika V. 2010. Iron deficiency in Indian children with attention deficit hyperactivity disorder. Indian Pediatr 47: 955- 958.
66. Kent L, Middle F, Hawi Z, Fitzgerald M, Gill M, Feehan C, Craddock N. 2001. Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr Genet 11: 37- 40.
67. Kent L, Green E, Hawi Z, Kirley A, Dudbridge F, Lowe N, Raybould R, et al. 2005. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphismof the brain-derived neurotrophic factor [BDNF] gene with susceptibility to ADHD. Mol Psychiatry 10: 939- 943.
68. Kereszturi E, Kiraly O, Csapo Z, Tarnok Z, Gadoros J, Sasvari-Szekely M, Nemoda Z. 2007. Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: Genetic and molecular analyses. Am J Med Genet Part B 144B: 231- 236.
69. Knopik VS, Heath AC, Jacob T, Slutske WS, Bucholz KK, Madden PAF, Waldron M, et al. 2006. Maternal alcohol use disorder and offspring ADHD: Disentangling genetic and environmental effects using a children-of-twins design. Psychol Med 36: 1461- 1471.
70. Konofal E, Lecendreux M, Arnulf I, Mouren MC. 2004. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 158: 1113- 1115.
71. Koshy G, Delpisheh A, Brabin BJ. 2011. Childhood obesity and parental smoking as risk factors for childhood ADHD in Liverpool children. Atten Defic Hyperact Disord 3: 21- 28.
72. Kusaga A. 2002. Decreased beta-phenylethylamine in urine of children with attention deficit hyperactivity disorder and autistic disorder. No To Hattatsu 34: 243- 248 (in Japanese).
73. Kusaga A, Yamashita Y, Koeda T, Hiratani M, Kaneko M, Yamada S, Matsuishi T. 2002. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Ann Neurol 52: 372- 374.
74. Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, et al. 2004. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: Confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry 9: 711- 717.
75. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1: 121- 124.
76. Lang UE, Hellweg R, Sander T, Gallinat J. 2009. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 142: 120- 122.
77. Langley K, Marshall L, van den Bree M, Thomas H, Owen M, O'Donovan M, Thapar A. 2004. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry 161: 133- 138.
78. Li D, Sham PC, Owen MJ, He L. 2006. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15: 2276- 2284.
79. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone SV. 2007. Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet Part B 144B: 14- 19.
80. Lindblad F, Hjern A. 2010. ADHD after fetal exposure to maternal smoking. Nicotine Tobacco Res 12: 408- 415.
81. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, et al. 2004. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 74: 348- 356.
82. Lozoff B. 2011. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr 141: 740S- 746S.
83. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein RP, Kotler M. 2001. Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet 105: 91- 95.
84. McCracken JT, Smalley SL, McGough JJ, Crawford L, Del'Homme M, Cantor RM, Liu A, et al. 2000. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 5: 531- 536.
85. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. 2002. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 41: 378- 385.
86. Mick E, Todorov A, Smalley S, Hu X, Loo S, Todd RD, Biederman J, et al. 2010. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49: 898- 905, e3.
87. Mitchell EA, Aman MG, Turbott SH, Manku M. 1987. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr 26: 406- 411.
88. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, Vasquez AA, et al. 2008. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet Part B 147B(8): 1337- 1344.
89. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Faraone SV, et al. 2010. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49: 884- 897.
90. Nigg JT, Breslau N. 2007. Prenatal smoking exposure, low birth weight, and disruptive behavior disorders. J Am Acad Child Adolesc Psychiatr 46: 362- 369.
91. Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W, Rappley MD. 2008. Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biological Psychiatry 63: 325- 331.
92. Nigg JT, Nikolas M, Mark Knottnerus G, Cavanagh K, Friderici K. 2010. Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels. J Child Psychol Psychiatry 51: 58- 65.
93. Noain D, Avale ME, Wedemeyer C, Calvo D, Peper M, Rubinstein M. 2006. Identification of brain neurons expressing the dopamine D4 receptor gene using BAC transgenic mice. Eur J NeuroSci 24: 2429- 2438.
94. O'Connor DT, Levine GL, Frigon RP. 1983. Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: Analysis of homospecific activity, circulating plasma pool and inter groups differences based on race, blood pressure and cardiac function. J Hypertens 1: 227- 233.
95. Oades RD, Daniels R, Rascher W. 1998. Plasma neuropeptide-Y, monoamine metabolism, electrolyte excretion and drinking behaviour in children with attention-deficit hyperactivity disorder. Psychiatry Res 80: 177- 186.
96. Oades RD, Slusarek M, Velling S, Bondy B. 2002. Serotonin platelet transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): Clinical versus experimental measures of impulsivity. World J Biol Psychiatry 3: 96- 100.
97. Park L, Nigg JT, Waldman ID, Nummy KA, Huang-Pollock C, Rappley M, Friderici KH. 2005. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10: 572- 580.
98. Park MJ, Guest CB, Barnes MB, Martin J, Ahmad U, York JM, Freund GG. 2008. Blocking of beta-2 adrenergic receptors hastens recovery from hypoglycemia-associated social withdrawal. Psychoneuroendocrinology 33: 1411- 1418.
99. Pe'er I, Yelensky R, Altshuler D, Daly MJ. 2008. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 32: 381- 385.
100. Purper-Ouakil D, Wohl M, Mouren MC, Verpillat P, Adès J, Gorwood P. 2005. Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatry Genet 15: 53- 59.
101. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV. 2003. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet Part B 118B: 103- 109.
102. Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, Basile VS, et al. 2000. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 5: 537- 541.
103. Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, Basile VS, et al. 2003. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol Psychiatry 8: 98- 102.
104. Reneman L, De Bruin K, Lavalaye J, Gunning WB, Booij J. 2001. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse 39: 193- 200.
105. Ribases M, Ramos-Quiroga JA, Hervas A, Bosch R, Bielsa A, Gastaminza X, Artigas J, et al. 2009. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry 14: 71- 85.
106. Richardson AJ. 2006. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry 18: 155- 172.
107. Richardson AJ, Ross MA. 2000. Fatty acid metabolism in neurodevelopmental disorder: A new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids 63: 1- 9.
108. Rogeness GA, Maas JW, Javors MA, Macedo CA, Fischer C, Harris WR. 1989. Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res 27: 241- 251.
109. Sagvolden T. 2000. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24: 31- 39.
110. Sandyk R. 1990. Zinc deficiency in attention-deficit/hyperactivity disorder. Int J Neurosci 52: 239- 241.
111. Semrud-Clikeman M, Steingard RJ, Filipek P, Biederman J, Bekken K, Renshaw PF. 2000. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 39: 477- 484.
112. Shekim WO, Dekirmenjian H, Chapel JL. 1979. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine. Am J Psychiatry 136: 667- 671.
113. Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, Navia BA. 2003. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee Longitudinal Study. Am J Med Genet Part B 119B: 77- 85.
114. Smoller JW, Biederman J, Arbeitman L, Doyle AE, Fagerness J, Perlis RH, Sklar P, et al. 2006. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry 59: 460- 467.
115. Spencer T, Biederman J, Wilens T. 1999. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin N Am 46: 915- 927.
116. Spencer TJ, Biederman J, Wilens TE, Faraone SV. 2002. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 63: 3- 9.
117. Starobrat-Hermelin B. 1998. The effect of deficiency of selected bio-elements on hyperactivity in children with certain specified mental disorders. Ann Acad Med Stetin 44: 297- 314 (in Polish).
118. Starobrat-Hermelin B, Kozielec T. 1997. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 10: 149- 156.
119. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR. 1995. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 62: 761- 768.
120. Thapar A, Fowler T, Rice F, Scourfield J, van den Bree M, Thomas H, Harold G, et al. 2003. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 160: 1985- 1989.
121. Thapar A, Langley K, Fowler T, Rice F, Turic D, Whittinger N, Aggleton J, et al. 2005. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 62: 1275- 1278.
122. Todd RD, Lobos EA, Sun LW, Neuman RJ. 2003. Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: Evidence for association of an intronic polymorphism with attention problems. Mol Psychiatry 8: 103- 108.
123. Toren P, Eldar S, Sela BA, Wolmer L, Weitz R, Inbar D, Koren S, et al. 1996. Zinc deficiency in attention-deficit hyperactivity disorder. Biol Psychiatry 40: 1308- 1310.
124. Turic D, Williams H, Langley K, Owen M, Thapar A, O'Donovan MC. 2005. A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD). Am J Med Genet Part B 133B: 64- 67.
125. Volkow ND, Fowler JS. 2000. Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cereb Cortex 10: 318- 325.
126. Waldman I, Gizer I. 2006. The genetics of attention deficit hyperactivity disorder. Clin Psychol Rev 26: 396- 432.
127. Webb TE, Krill CE Jr, Oski FA, Tsou KC. 1982. Relationship of iron status to urinary norepinephrine excretion in children 7-12 years of age. J Pediatr Gastroenterol Nutr 1: 207- 209.
128. Weinshilboum RM. 1978. Serum dopamine beta-hydroxylase. Pharmacol Rev 30: 133- 166.
129. Wilens TE, Dodson W. 2004. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry 65: 1301- 1313.
130. Xu C, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL, Barr CL. 2001. Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am J Med Genet 105: 159- 162.
131. Xu X, Mill J, Zhou K, Brookes K, Chen CK, Asherson P. 2007. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am J Med Genet Part B 144B: 83- 86.
132. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY. 2007. A meta-analysis of association studies between the 10-repeat allele of a VNTRpolymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet Part B 144B: 541- 550.
133. Yasong D, Linyan S, Xuerong L. 1998. Measurement of serum catecholamines in boys with attention deficit hyperactivity disorder. Chin J Psychiatry 31: 30- 33.
134. Yoshimasu K, Kiyohara C, Minami T, Yoshikawa N, Kihira S, Toyonaga K, Yamamoto A, et al. 2009. Maternal smoking during pregnancy and offspring attention-deficit/hyperactivity disorder: A case-control study in Japan. Atten Defic Hyperact Disord 1: 223- 231.
135. Zabetian CP, Buxbaum SG, Elston RC, Kohnke MD, Anderson GM, Gelernter J, Cubells JF. 2003. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine betahydroxylase activity. Am J Hum Genet 72: 1389- 1400.
136. Zametkin AJ, Rapoport JL. 1987. Neurobiology of ADHD. J Am Acad Child Adolesc Psychiatry 26: 676- 686.